1. Home
  2. SRRK vs HWC Comparison

SRRK vs HWC Comparison

Compare SRRK & HWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$47.76

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo Hancock Whitney Corporation

HWC

Hancock Whitney Corporation

HOLD

Current Price

$76.51

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
HWC
Founded
2012
1883
Country
United States
United States
Employees
N/A
3658
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.6B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SRRK
HWC
Price
$47.76
$76.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
6
Target Price
$56.17
$77.67
AVG Volume (30 Days)
1.2M
935.7K
Earning Date
05-07-2026
04-21-2026
Dividend Yield
N/A
3.00%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.59
Revenue Next Year
$534.24
$4.42
P/E Ratio
N/A
$12.48
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$54.05
52 Week High
$58.49
$79.36

Technical Indicators

Market Signals
Indicator
SRRK
HWC
Relative Strength Index (RSI) 39.63 58.22
Support Level $45.46 $66.24
Resistance Level $48.23 $79.36
Average True Range (ATR) 2.44 1.44
MACD -1.01 -0.25
Stochastic Oscillator 6.24 54.07

Price Performance

Historical Comparison
SRRK
HWC

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About HWC Hancock Whitney Corporation

Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.

Share on Social Networks: